Entrada Therapeutics Stock Price on March 13, 2024

TRDA Stock  USD 10.80  0.31  2.96%   
If you're considering investing in Entrada Stock, it is important to understand the factors that can impact its price. As of today, the current price of Entrada Therapeutics stands at 10.80, as last reported on the 25th of March, with the highest price reaching 10.81 and the lowest price hitting 10.61 during the day. Entrada Therapeutics secures Sharpe Ratio (or Efficiency) of -0.24, which denotes the company had a -0.24 % return per unit of risk over the last 3 months. Entrada Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Entrada Therapeutics' Mean Deviation of 2.49, standard deviation of 3.26, and Variance of 10.62 to check the risk estimate we provide.
  
Entrada Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.237

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsTRDA

Estimated Market Risk

 3.3
  actual daily
29
71% of assets are more volatile

Expected Return

 -0.78
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.24
  actual daily
0
Most of other assets perform better
Based on monthly moving average Entrada Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Entrada Therapeutics by adding Entrada Therapeutics to a well-diversified portfolio.

Entrada Therapeutics Valuation on March 13, 2024

It is possible to determine the worth of Entrada Therapeutics on a given historical date. On March 13, 2024 Entrada was worth 12.09 at the beginning of the trading date compared to the closed value of 12.71. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Entrada Therapeutics stock. Still, in general, we apply an absolute valuation method to find Entrada Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Entrada Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Entrada Therapeutics' related companies.
 Open High Low Close Volume
  11.74    11.97    11.43    11.58    74,662  
03/13/2024
  12.09    12.82    11.35    12.71    171,004  
  12.35    12.88    11.87    12.20    90,555  
Backtest Entrada Therapeutics  |  Entrada Therapeutics History  |  Entrada Therapeutics Valuation   PreviousNext  
Open Value
12.09
12.71
Closing Value
22.00
Upside

Entrada Therapeutics Trading Date Momentum on March 13, 2024

On March 14 2024 Entrada Therapeutics was traded for  12.20  at the closing time. The top price for the day was 12.88  and the lowest listed price was  11.87 . The trading volume for the day was 90.6 K. The trading history from March 14, 2024 was a factor to the next trading day price decrease. The trading price change against the next closing price was 4.01% . The overall trading delta against the current closing price is 9.05% .

Entrada Therapeutics Fundamentals Correlations and Trends

By evaluating Entrada Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Entrada Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Entrada financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Entrada Therapeutics Stock history

Entrada Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Entrada is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Entrada Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Entrada Therapeutics stock prices may prove useful in developing a viable investing in Entrada Therapeutics
Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle therapeutics for the treatment of multiple neuromuscular diseases. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts. Entrada Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 122 people.

Entrada Therapeutics Stock Technical Analysis

Entrada Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Entrada Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Entrada Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Entrada Therapeutics Period Price Range

Low
March 25, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Entrada Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Entrada Therapeutics March 25, 2025 Market Strength

Market strength indicators help investors to evaluate how Entrada Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Entrada Therapeutics shares will generate the highest return on investment. By undertsting and applying Entrada Therapeutics stock market strength indicators, traders can identify Entrada Therapeutics entry and exit signals to maximize returns

Entrada Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Entrada Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Entrada Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Entrada to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Entrada Stock analysis

When running Entrada Therapeutics' price analysis, check to measure Entrada Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entrada Therapeutics is operating at the current time. Most of Entrada Therapeutics' value examination focuses on studying past and present price action to predict the probability of Entrada Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entrada Therapeutics' price. Additionally, you may evaluate how the addition of Entrada Therapeutics to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Money Managers
Screen money managers from public funds and ETFs managed around the world
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges